Status:

UNKNOWN

Use of Mysimba in Patients With Weight Regain After Bariatric Surgery

Lead Sponsor:

Zuyderland Medisch Centrum

Collaborating Sponsors:

Nederlandse Obesitas Kliniek

Conditions:

Obesity, Morbid

Bariatric Surgery Candidate

Eligibility:

All Genders

18-74 years

Phase:

PHASE4

Brief Summary

Although bariatric surgery is currently the most effective treatment for morbid obesity, weight regain occurs in 16-37% of the patients (1). Weight regain is not regularly treated with antiobesity med...

Detailed Description

Throughout the years it has become clear that lifestyle intervention is the cornerstone for all types of bariatric treatment. Educating patients about behaviour, physical activity and intake strategie...

Eligibility Criteria

Inclusion

  • BMI before surgery was ≥ 35,0 kg/m2
  • Patient has undergone a primary banded/non-banded Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG)
  • Gaining more than 5% weight after reaching plateau phase of lowest weight

Exclusion

  • Anatomical or surgical abnormalities for which revisional surgery is indicated.
  • Use of the following medication Monoamino-oxidase inbibitors (MAO), selective serotonin reuptake inhibitor (SSRI), Tricyclic antidepressants (TCA), haloperidol, risperidone, opioids, antiarrhythmics, betablockers, antiviral medication (HIV)
  • Pregnancy or breastfeeding
  • Patients suffering from:
  • unregulated hypertension
  • a tumour in the central nervous system
  • severe liver failure
  • end stage kidney failure
  • Patients suffering from or with a history of insults
  • Patients with a history of:
  • bipolar disease
  • bulimia or anorexia nervosa
  • Patients withdrawing from alcohol or benzodiazepines
  • Patients who are not able to understand the informed consent form and patient information.

Key Trial Info

Start Date :

March 21 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2025

Estimated Enrollment :

116 Patients enrolled

Trial Details

Trial ID

NCT04902625

Start Date

March 21 2023

End Date

March 1 2025

Last Update

May 30 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Zuyderland Medical Center

Heerlen, Limburg, Netherlands, 6419 PC